Journal of Peking University (Health Sciences) ›› 2022, Vol. 54 ›› Issue (5): 814-821. doi: 10.19723/j.issn.1671-167X.2022.05.006

Previous Articles     Next Articles

宁 张*(),慧 杨,鹏 王   

  • Received:2022-08-04 Online:2022-10-18 Published:2022-10-14
  • Contact: 宁 张 E-mail:zhangning@bjmu.edu.cn

RICH HTML

  

CLC Number: 

  • R735.3
1 Wu C , Li M , Meng H , et al. Analysis of status and countermeasures of cancer incidence and mortality in China[J]. Sci China Life Sci, 2019, 62 (5): 640- 647.
doi: 10.1007/s11427-018-9461-5
2 Li L , Knutsdottir H , Hui K , et al. Human primary liver cancer organoids reveal intratumor and interpatient drug response heterogeneity[J]. JCI Insight, 2019, 4 (2): e121490.
doi: 10.1172/jci.insight.121490
3 Gillet JP , Varma S , Gottesman MM . The clinical relevance of cancer cell lines[J]. J Natl Cancer Inst, 2013, 105 (7): 452- 458.
doi: 10.1093/jnci/djt007
4 Byrne AT , Alferez DG , Amant F , et al. Interrogating open issues in cancer precision medicine with patient-derived xenografts[J]. Nat Rev Cancer, 2017, 17 (4): 254- 268.
doi: 10.1038/nrc.2016.140
5 Gao H , Korn JM , Ferretti S , et al. High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response[J]. Nat Med, 2015, 21 (11): 1318- 1325.
doi: 10.1038/nm.3954
6 Sato T , Vries RG , Snippert HJ , et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche[J]. Nature, 2009, 459 (7244): 262- 265.
doi: 10.1038/nature07935
7 Jacob F , Salinas RD , Zhang DY , et al. A patient-derived glioblastoma organoid model and biobank recapitulates inter- and intra-tumoral heterogeneity[J]. Cell, 2020, 180 (1): 188- 204.
doi: 10.1016/j.cell.2019.11.036
8 Fujii M , Shimokawa M , Date S , et al. A colorectal tumor organoid library demonstrates progressive loss of niche factor requirements during tumorigenesis[J]. Cell Stem Cell, 2016, 18 (6): 827- 838.
doi: 10.1016/j.stem.2016.04.003
9 Rosenbluth JM , Schackmann RCJ , Gray GK , et al. Organoid cultures from normal and cancer-prone human breast tissues preserve complex epithelial lineages[J]. Nat Commun, 2020, 11 (1): 1711.
doi: 10.1038/s41467-020-15548-7
10 Sato T , Stange DE , Ferrante M , et al. Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium[J]. Gastroenterology, 2011, 141 (5): 1762- 1772.
doi: 10.1053/j.gastro.2011.07.050
11 Huch M , Dorrell C , Boj SF , et al. In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration[J]. Nature, 2013, 494 (7436): 247- 250.
doi: 10.1038/nature11826
12 Schwarz JS , de Jonge HR , Forrest JN . Value of organoids from comparative epithelia models[J]. Yale J Biol Med, 2015, 88 (4): 367- 374.
13 Huch M , Gehart H , van Boxtel R , et al. Long-term culture of genome-stable bipotent stem cells from adult human liver[J]. Cell, 2015, 160 (1/2): 299- 312.
14 Bartfeld S , Bayram T , van de Wetering M , et al. In vitro expansion of human gastric epithelial stem cells and their responses to bacterial infection[J]. Gastroenterology, 2015, 148 (1): 126- 136.
doi: 10.1053/j.gastro.2014.09.042
15 Sachs N , de Ligt J , Kopper O , et al. A living biobank of breast cancer organoids captures disease heterogeneity[J]. Cell, 2018, 172 (1/2): 373- 386.
16 Hostiuc S , Rusu MC , Negoi I , et al. The moral status of cerebral organoids[J]. Regen Ther, 2019, 10, 118- 122.
doi: 10.1016/j.reth.2019.02.003
17 Drost J , Clevers H . Organoids in cancer research[J]. Nat Rev Cancer, 2018, 18 (7): 407- 418.
doi: 10.1038/s41568-018-0007-6
18 Broutier L , Andersson-Rolf A , Hindley CJ , et al. Culture and establishment of self-renewing human and mouse adult liver and pancreas 3D organoids and their genetic manipulation[J]. Nat Protoc, 2016, 11 (9): 1724- 1743.
doi: 10.1038/nprot.2016.097
19 Fong ELS , Toh TB , Lin QXX , et al. Generation of matched patient-derived xenograft in vitro-in vivo models using 3D macroporous hydrogels for the study of liver cancer[J]. Biomaterials, 2018, 159, 229- 240.
doi: 10.1016/j.biomaterials.2017.12.026
20 Tamai M , Adachi E , Tagawa Y . Characterization of a liver organoid tissue composed of hepatocytes and fibroblasts in dense collagen fibrils[J]. Tissue Eng Part A, 2013, 19 (21/22): 2527- 2535.
21 Robertson MJ , Soibam B , O'Leary JG , et al. Recellularization of rat liver: an in vitro model for assessing human drug metabolism and liver biology[J]. PLoS One, 2018, 13 (1): e0191892.
doi: 10.1371/journal.pone.0191892
22 Neal JT , Li X , Zhu J , et al. Organoid modeling of the tumor immune microenvironment[J]. Cell, 2018, 175 (7): 1972- 1988.
doi: 10.1016/j.cell.2018.11.021
23 Deng J , Wang ES , Jenkins RW , et al. CDK4/6 inhibition augments antitumor immunity by enhancing T-cell activation[J]. Cancer Discov, 2018, 8 (2): 216- 233.
doi: 10.1158/2159-8290.CD-17-0915
24 Dijkstra KK , Cattaneo CM , Weeber F , et al. Generation of tumor-reactive T Cells by co-culture of peripheral blood lymphocytes and tumor organoids[J]. Cell, 2018, 174 (6): 1586- 1598.
doi: 10.1016/j.cell.2018.07.009
25 Gao D , Vela I , Sboner A , et al. Organoid cultures derived from patients with advanced prostate cancer[J]. Cell, 2014, 159 (1): 176- 187.
doi: 10.1016/j.cell.2014.08.016
26 Barker N , Ridgway RA , van Es JH , et al. Crypt stem cells as the cells-of-origin of intestinal cancer[J]. Nature, 2009, 457 (7229): 608- 611.
doi: 10.1038/nature07602
27 van de Wetering M , Francies HE , Francis JM , et al. Prospective derivation of a living organoid biobank of colorectal cancer patients[J]. Cell, 2015, 161 (4): 933- 945.
doi: 10.1016/j.cell.2015.03.053
28 Yan HHN , Siu HC , Law S , et al. A comprehensive human gastric cancer organoid biobank captures tumor subtype heterogeneity and enables therapeutic screening[J]. Cell Stem Cell, 2018, 23 (6): 882- 897.
doi: 10.1016/j.stem.2018.09.016
29 Vlachogiannis G , Hedayat S , Vatsiou A , et al. Patient-derived organoids model treatment response of metastatic gastrointestinal cancers[J]. Science, 2018, 359 (6378): 920- 926.
doi: 10.1126/science.aao2774
30 Lee SH , Hu W , Matulay JT , et al. Tumor evolution and drug response in patient-derived organoid models of bladder cancer[J]. Cell, 2018, 173 (2): 515- 528.
doi: 10.1016/j.cell.2018.03.017
31 Boj SF , Hwang CI , Baker LA , et al. Organoid models of human and mouse ductal pancreatic cancer[J]. Cell, 2015, 160 (1/2): 324- 338.
32 Seino T , Kawasaki S , Shimokawa M , et al. Human pancreatic tumor organoids reveal loss of stem cell niche factor dependence during disease progression[J]. Cell Stem Cell, 2018, 22 (3): 454- 467.
doi: 10.1016/j.stem.2017.12.009
33 Kopper O , de Witte CJ , Lohmussaar K , et al. An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity[J]. Nat Med, 2019, 25 (5): 838- 849.
doi: 10.1038/s41591-019-0422-6
34 Lapointe S , Perry A , Butowski NA . Primary brain tumours in adults[J]. Lancet, 2018, 392 (10145): 432- 446.
doi: 10.1016/S0140-6736(18)30990-5
35 Broutier L , Mastrogiovanni G , Verstegen MM , et al. Human primary liver cancer-derived organoid cultures for disease modeling and drug screening[J]. Nat Med, 2017, 23 (12): 1424- 1435.
doi: 10.1038/nm.4438
36 Nuciforo S , Fofana I , Matter MS , et al. Organoid models of human liver cancers derived from tumor needle biopsies[J]. Cell Rep, 2018, 24 (5): 1363- 1376.
doi: 10.1016/j.celrep.2018.07.001
37 Zhao Y , Li ZX , Zhu YJ , et al. Single-cell transcriptome analysis uncovers intratumoral heterogeneity and underlying mechanisms for drug resistance in hepatobiliary tumor organoids[J]. Adv Sci (Weinh), 2021, 8 (11): e2003897.
doi: 10.1002/advs.202003897
38 Yuan B , Zhao X , Wang X , et al. Patient-derived organoids for personalized gallbladder cancer modelling and drug screening[J]. Clin Transl Med, 2022, 12 (1): e678.
39 Huang L , Holtzinger A , Jagan I , et al. Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell and patient-derived tumor organoids[J]. Nat Med, 2015, 21 (11): 1364- 1371.
doi: 10.1038/nm.3973
40 Matano M , Date S , Shimokawa M , et al. Modeling colorectal cancer using CRISPR-Cas9-mediated engineering of human intestinal organoids[J]. Nat Med, 2015, 21 (3): 256- 262.
doi: 10.1038/nm.3802
41 Drost J , van Jaarsveld RH , Ponsioen B , et al. Sequential cancer mutations in cultured human intestinal stem cells[J]. Nature, 2015, 521 (7550): 43- 47.
doi: 10.1038/nature14415
42 Sun L , Wang Y , Cen J , et al. Modelling liver cancer initiation with organoids derived from directly reprogrammed human hepatocytes[J]. Nat Cell Biol, 2019, 21 (8): 1015- 1026.
doi: 10.1038/s41556-019-0359-5
43 Skardal A , Shupe T , Atala A . Organoid-on-a-chip and body-on-a-chip systems for drug screening and disease modeling[J]. Drug Discov Today, 2016, 21 (9): 1399- 1411.
doi: 10.1016/j.drudis.2016.07.003
44 Uchino S , Kellum JA , Bellomo R , et al. Acute renal failure in critically ill patients: a multinational, multicenter study[J]. JAMA, 2005, 294 (7): 813- 818.
doi: 10.1001/jama.294.7.813
45 Morizane R , Lam AQ , Freedman BS , et al. Nephron organoids derived from human pluripotent stem cells model kidney development and injury[J]. Nat Biotechnol, 2015, 33 (11): 1193- 1200.
doi: 10.1038/nbt.3392
46 Eder A , Vollert I , Hansen A , et al. Human engineered heart tissue as a model system for drug testing[J]. Adv Drug Deliv Rev, 2016, 96, 214- 224.
doi: 10.1016/j.addr.2015.05.010
47 Voges HK , Mills RJ , Elliott DA , et al. Development of a human cardiac organoid injury model reveals innate regenerative potential[J]. Deve-lopment, 2017, 144 (6): 1118- 1127.
48 Lancaster MA , Renner M , Martin CA , et al. Cerebral organoids model human brain development and microcephaly[J]. Nature, 2013, 501 (7467): 373- 379.
doi: 10.1038/nature12517
49 Gjorevski N , Sachs N , Manfrin A , et al. Designer matrices for intestinal stem cell and organoid culture[J]. Nature, 2016, 539 (7630): 560- 564.
doi: 10.1038/nature20168
50 Tuveson D , Clevers H . Cancer modeling meets human organoid technology[J]. Science, 2019, 364 (6444): 952- 955.
doi: 10.1126/science.aaw6985
[1] Yu-mei LAI,Zhong-wu LI,Huan LI,Yan WU,Yun-fei SHI,Li-xin ZHOU,Yu-tong LOU,Chuan-liang CUI. Clinicopathological features and prognosis of anorectal melanoma: A report of 68 cases [J]. Journal of Peking University (Health Sciences), 2023, 55(2): 262-269.
[2] Wen-peng WANG,Jie-fu WANG,Jun HU,Jun-feng WANG,Jia LIU,Da-lu KONG,Jian LI. Clinicopathological features and prognosis of colorectal stromal tumor [J]. Journal of Peking University (Health Sciences), 2020, 52(2): 353-361.
[3] Xiao WANG,Zhao-xing LI,Huan-fang FAN,Li-ying WEI,Xu-jin GUO,Na GUO,Tong WANG. A rare case of cystadenoma in the small intestine [J]. Journal of Peking University (Health Sciences), 2020, 52(2): 382-384.
[4] Wei ZHANG,Ying-jiang YE,Xian-wen REN,Jing HUANG,Zhan-long SHEN. Detection of preoperative chemoradiotherapy sensitivity molecular characteristics of rectal cancer by transcriptome second generation sequencing [J]. Journal of Peking University(Health Sciences), 2019, 51(3): 542-547.
[5] CHEN He-kai, DAI Yun, WU Ting, WANG Xin, WAN Yuan-lian, TANG Jian-qiang. Mechanism of cross talk between tissue factor/active coagulation factor Ⅶ and epidermal growth factor receptor signalings in colon cancer cells in culture [J]. Journal of Peking University(Health Sciences), 2017, 49(6): 931-936.
[6] ZHAO Yi-guo, YANG Xiao-dong, ZHANG Yan-kai, NING Ning, XING Zhao-dong, YE Ying-jiang. #br# Adenocarcinoma in a Meckel’s diverticulum with multiple liver metastases and gastrointestinal hemorrhage: a case report [J]. Journal of Peking University(Health Sciences), 2017, 49(6): 1095-1097.
[7] CHEN Yang, WANG Yan-rong, SHI Yan, DAI Guang-hai. Prognostic value of chemotherapy-induced neutropenia in metastatic colon cancer patients undergoing first-line chemotherapy with FOLFOX [J]. Journal of Peking University(Health Sciences), 2017, 49(4): 669-674.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!